{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:09:56Z","timestamp":1792012196765,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clae.2024.102191","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T05:03:14Z","timestamp":1719637394000},"page":"102191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapies"],"prefix":"10.1016","volume":"47","author":[{"given":"Shehzad A.","family":"Naroo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Gil-Cazorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Collazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Eperjesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnMarie","family":"Hipsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin R.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0005","first-page":"102155","volume":"47","author":"Wolffsohn","year":"2024","journal-title":"BCLA CLEAR presbyopia: definitions. cont lens anterior eye"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0010","first-page":"102185","volume":"47","author":"Davies","year":"2024","journal-title":"BCLA CLEAR presbyopia: mechanism and optics. cont lens anterior eye"},{"key":"10.1016\/j.clae.2024.102191_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102157","article-title":"BCLA CLEAR presbyopia: epidemiology and impact","author":"Markoulli","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mattod.2014.01.019","article-title":"Molecular biomechanics of collagen molecules","volume":"17","author":"Chang","year":"2014","journal-title":"Mater Today"},{"issue":"1\u20132","key":"10.1016\/j.clae.2024.102191_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(98)00119-5","article-title":"Mechanisms of maturation and ageing of collagen","volume":"106","author":"Bailey","year":"1998","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0030","doi-asserted-by":"crossref","DOI":"10.1115\/1.4029430","article-title":"Collagen structure and mechanical properties of the human sclera: analysis for the effects of age","volume":"137","author":"Coudrillier","year":"2015","journal-title":"J Biomech Eng"},{"issue":"8","key":"10.1016\/j.clae.2024.102191_b0035","first-page":"2244","article-title":"The three-dimensional organization of collagen fibrils in the human cornea and sclera","volume":"32","author":"Komai","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clae.2024.102191_b0045","series-title":"Ocular rigidity, biomechanics and hydrodynamics of the eye","first-page":"77","article-title":"Biomechanical properties of the sclera","author":"Campbell","year":"2021"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/exer.2000.0972","article-title":"Age-dependent changes in the expression of matrix components in the mouse eye","volume":"72","author":"Ihanamaki","year":"2001","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clae.2024.102191_b0055","series-title":"Ocular rigidity, biomechanics and hydrodynamics of the eye","first-page":"15","article-title":"Ocular rigidity: clinical approach","author":"Kotliar","year":"2021"},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0060","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1167\/iovs.09-3760","article-title":"Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure","volume":"50","author":"Dastiridou","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1167\/iovs.04-0162","article-title":"Ocular rigidity in living human eyes","volume":"46","author":"Pallikaris","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10237-021-01417-9","article-title":"The action of ciliary muscle contraction on accommodation of the lens explored with a 3D model","volume":"20","author":"Knaus","year":"2021","journal-title":"Biomech Model Mechanobiol"},{"issue":"7","key":"10.1016\/j.clae.2024.102191_b0075","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1167\/iovs.12-10847","article-title":"Accommodative movements of the vitreous membrane, choroid, and sclera in young and presbyopic human and nonhuman primate eyes","volume":"54","author":"Croft","year":"2013","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004397-200104000-00005","article-title":"Accommodation and presbyopia","volume":"41","author":"Croft","year":"2001","journal-title":"Int Ophthalmol Clin"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archopht.1992.01080180143043","article-title":"Age-related loss of ciliary muscle mobility in the rhesus monkey","volume":"110","author":"Tamm","year":"1992","journal-title":"Role Choroid Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bjo.2005.086579","article-title":"An experimental study of the elastic properties of the human Bruch's membrane-choroid complex: relevance to ageing","volume":"90","author":"Ugarte","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/j.jcrs.0000000000000744","article-title":"Force of lifelong crystalline lens growth: chronic traumatic mechanical insult to the choroid","volume":"48","author":"Strenk","year":"2022","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.1973.sp010111","article-title":"Presbyopia and the changes with age in the human crystalline lens","volume":"228","author":"Fisher","year":"1973","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1167\/iovs.02-0256","article-title":"Polymer refilling of presbyopic human lenses in vitro restores the ability to undergo accommodative changes","volume":"44","author":"Koopmans","year":"2003","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12886-020-01404-1","article-title":"In vivo ultraosound elastographic evaluation of the age-related change of human lens nuclear stiffness","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1442-9071.2012.02809.x","article-title":"Ocular rigidity: biomechanical role, in vivo measurements and clinical significance","volume":"41","author":"Detorakis","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.clae.2024.102191_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40662-017-0081-y","article-title":"Visual outcomes 24 months after LaserACE","volume":"4","author":"Hipsley","year":"2017","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.13-6","article-title":"Effects of astaxanthin on antioxidation in human aqueous humor","volume":"53","author":"Hashimoto","year":"2013","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.clae.2024.102191_b0130","series-title":"Ocular rigidity, biomechanics and hydrodynamics of the eye","first-page":"127","article-title":"Influence of ocular rigidity and ocular biomechanics on the pathogenesis of age-related presbyopia","author":"Hipsley","year":"2021"},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.11.12.2","article-title":"Improvement in accommodation and dynamic range of focus after laser scleral microporation: a potential treatment for presbyopia","volume":"11","author":"Ting","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ismej.2007.59","article-title":"Colorful niches of phototrophic microorganisms shaped by vibrations of the water molecule","volume":"1","author":"Stomp","year":"2007","journal-title":"ISME J"},{"key":"10.1016\/j.clae.2024.102191_b0145","unstructured":"Yumeen S, Hohman MH, Khan T. Laser erbium-YAG resurfacing. StatPearls [Internet]: StatPearls Publishing; 2023."},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0150","doi-asserted-by":"crossref","first-page":"102190","DOI":"10.1016\/j.clae.2024.102190","article-title":"BCLA CLEAR presbyopia: management with corneal techniques","volume":"47","author":"Craig","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.clae.2024.102191_b0155","doi-asserted-by":"crossref","unstructured":"Schnider C, Hsu Yuen L, Rampat R, Zhu D, Dhallu S, Trinh T, Gurnani B, Abdelmaksoud A, Wolffsohn JS, Naroo SA BCLA CLEAR presbyopia: management with intraocular lenses. Cont Lens Anterior Eye 2024;48(4) [in press].","DOI":"10.1016\/j.clae.2024.102253"},{"key":"10.1016\/j.clae.2024.102191_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40662-018-0098-x","article-title":"Scleral surgery for the treatment of presbyopia: where are we today?","volume":"5","author":"Hipsley","year":"2018","journal-title":"Eye Vis (Lond)"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.4.6","article-title":"Tissue responses and wound healing following laser scleral microporation for presbyopia therapy","volume":"9","author":"Liu","year":"2020","journal-title":"Transl vis Sci Technol"},{"key":"10.1016\/j.clae.2024.102191_b0170","unstructured":"Schachar RA. Cause and treatment of presbyopia with a method for increasing the amplitude of accommodation. Ann Ophthalmol 1992;24(12):445-7, 52."},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0175","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0161-6420(01)00591-7","article-title":"Scleral expansion bands for presbyopia","volume":"108","author":"Malecaze","year":"2001","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0002-9394(02)01831-7","article-title":"Implantation of scleral expansion band segments for the treatment of presbyopia","volume":"134","author":"Qazi","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0301-4738.97554","article-title":"Supraciliary contraction segments: a new method for the treatment of presbyopia","volume":"62","author":"Tunc","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0190","first-page":"36","article-title":"Zonular function: a new hypothesis with clinical implications","volume":"26","author":"Schachar","year":"1994","journal-title":"Ann Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0195","first-page":"4","article-title":"A physical model demonstrating Schachar's hypothesis of accommodation","volume":"26","author":"Schachar","year":"1994","journal-title":"Ann Ophthalmol"},{"issue":"3 Pt 2","key":"10.1016\/j.clae.2024.102191_b0200","first-page":"R670","article-title":"In vivo increase of the human lens equatorial diameter during accommodation","volume":"271","author":"Schachar","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.clae.2024.102191_b0205","unstructured":"VisAbility. A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients 2015 [cited 2024 April]. Clinical Trial Repository]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02374671."},{"issue":"11","key":"10.1016\/j.clae.2024.102191_b0210","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0042-6989(98)00283-1","article-title":"Biometric, optical and physical changes in the isolated human crystalline lens with age in relation to presbyopia","volume":"39","author":"Glasser","year":"1999","journal-title":"Vision Res"},{"key":"10.1016\/j.clae.2024.102191_b0215","first-page":"956","article-title":"Massive increase in the stiffness of the human lens nucleus with age: the basis for presbyopia?","volume":"10","author":"Heys","year":"2004","journal-title":"Mol vis"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2004.10.010","article-title":"Dynamic mechanical properties of human lenses","volume":"80","author":"Weeber","year":"2005","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0225","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41433-020-01391-z","article-title":"Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial","volume":"35","author":"Korenfeld","year":"2021","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0230","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1167\/iovs.15-18413","article-title":"Protein disulfide levels and lens elasticity modulation: applications for presbyopia","volume":"57","author":"Garner","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2024.102191_b0235","unstructured":"EV06. A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects with Presbyopia 2015 [updated 2018; cited 2024 April]. Clinical Trial Repository]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02516306."},{"key":"10.1016\/j.clae.2024.102191_b0240","unstructured":"UNR844. A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. 2019 [cited 2024 April]. Clinical Trial Repository]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03809611."},{"issue":"11","key":"10.1016\/j.clae.2024.102191_b0245","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.jcrs.2009.06.019","article-title":"Visualization of femtosecond laser pulse-induced microincisions inside crystalline lens tissue","volume":"35","author":"Stachs","year":"2009","journal-title":"J Cataract Refract Surg"},{"issue":"5\u20136","key":"10.1016\/j.clae.2024.102191_b0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbio.201000013","article-title":"Femtosecond lentotomy: generating gliding planes inside the crystalline lens to regain accommodation ability","volume":"3","author":"Lubatschowski","year":"2010","journal-title":"J Biophoton"},{"issue":"14","key":"10.1016\/j.clae.2024.102191_b0255","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.visres.2009.04.028","article-title":"Femtosecond laser induced flexibility change of human donor lenses","volume":"49","author":"Schumacher","year":"2009","journal-title":"Vision Res"},{"issue":"11","key":"10.1016\/j.clae.2024.102191_b0260","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0161-6420(01)00834-X","article-title":"Experimental increase in accommodative potential after neodymium: yttrium-aluminum-garnet laser photodisruption of paired cadaver lenses","volume":"108","author":"Krueger","year":"2001","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.clae.2024.102191_b0265","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1167\/iovs.14-16185","article-title":"Measurement of ex vivo porcine lens shape during simulated accommodation, before and after fs-laser treatment","volume":"56","author":"Hahn","year":"2015","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"7","key":"10.1016\/j.clae.2024.102191_b0270","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/lsm.22154","article-title":"Safety evaluation of femtosecond lentotomy on the porcine lens by optical measurement with 50-femtosecond laser pulses","volume":"45","author":"Zhang","year":"2013","journal-title":"Lasers Surg Med"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0275","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00417-007-0699-x","article-title":"fs-Laser induced elasticity changes to improve presbyopic lens accommodation","volume":"246","author":"Ripken","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0280","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.jcrs.2005.05.034","article-title":"First safety study of femtosecond laser photodisruption in animal lenses: tissue morphology and cataractogenesis","volume":"31","author":"Krueger","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IIO.0b013e31820f8844","article-title":"Femtosecond laser photodisruption of the crystalline lens for restoring accommodation","volume":"51","author":"Reggiani Mello","year":"2011","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0290","doi-asserted-by":"crossref","first-page":"102158","DOI":"10.1016\/j.clae.2024.102158","article-title":"BCLA CLEAR presbyopia: contact lenses and spectacles","volume":"47","author":"Morgan","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"Pt 1","key":"10.1016\/j.clae.2024.102191_b0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/eye.1996.21","article-title":"Drug-induced ciliary body oedema: a new theory","volume":"10","author":"Krieg","year":"1996","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0300","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9394(14)72174-9","article-title":"Choroidal effusion as a mechanism for transient myopia induced by hydrochlorothiazide and triamterene","volume":"120","author":"Soylev","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0305","first-page":"224","article-title":"Suggested mechanism for acute transient myopia after sulfonamide treatment","volume":"25","author":"Grinbaum","year":"1993","journal-title":"Ann Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2024.102191_b0310","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/IJG.0000000000000742","article-title":"Drug-induced myopia and bilateral angle closure secondary to zolmitriptan","volume":"26","author":"Lee","year":"2017","journal-title":"J Glaucoma"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0315","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0253-7613.45156","article-title":"Ocular adverse effects of topiramate: two case reports","volume":"40","author":"Mandal","year":"2008","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0320","first-page":"103","article-title":"Acute myopia and angle closure glaucoma associated with topiramate use in a young patient: case report","volume":"72","author":"Brandao","year":"2009","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0028-3886.15074","article-title":"Acute myopia induced by topiramate: report of a case and review of the literature","volume":"53","author":"Bhattacharyya","year":"2005","journal-title":"Neurol India"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0330","first-page":"215","article-title":"Bilateral acute angle closure glaucoma and myopia induced by topiramate","volume":"160","author":"Cruciani","year":"2009","journal-title":"Clin Ter"},{"key":"10.1016\/j.clae.2024.102191_b0335","doi-asserted-by":"crossref","first-page":"241","DOI":"10.12659\/AJCR.881366","article-title":"Acute myopia and angle closure glaucoma associated with topiramate use: a case series","volume":"11","author":"Dehghani","year":"2010","journal-title":"Am J Case Rep"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0340","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","article-title":"Ocular adverse effects of common psychotropic agents: a review","volume":"24","author":"Richa","year":"2010","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13760-012-0022-4","article-title":"Topiramate-induced acute myopia with MRI contrast enhancement","volume":"112","author":"Latini","year":"2012","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0350","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00347-010-2276-7","article-title":"Panic after LASIK: acute medication-induced myopic recurrence after refractive surgery","volume":"108","author":"Muether","year":"2011","journal-title":"Ophthalmologe"},{"issue":"10","key":"10.1016\/j.clae.2024.102191_b0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/jpc.13606","article-title":"Acute bilateral myopia caused by lamotrigine-induced uveal effusions","volume":"53","author":"Woodcock","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.clae.2024.102191_b0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2431-14-96","article-title":"Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature","volume":"14","author":"Rapoport","year":"2014","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0365","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s10792-017-0740-y","article-title":"Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review","volume":"38","author":"Lan","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0370","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12886-019-1230-y","article-title":"Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion","volume":"19","author":"Kang","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.clae.2024.102191_b0375","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3341\/jkos.2020.61.12.1538","article-title":"Acute myopic shift and change in anterior chamber depth after intake of zonisamide","volume":"61","author":"Kim","year":"2020","journal-title":"J Korean Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0380","doi-asserted-by":"crossref","first-page":"728","DOI":"10.29271\/jcpsp.2021.06.728","article-title":"Topiramate-induced acute transient myopia and angle narrowing","volume":"31","author":"Khan","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"issue":"8","key":"10.1016\/j.clae.2024.102191_b0385","first-page":"e28513","article-title":"The ophthalmic side effects of topiramate: a review","volume":"14","author":"Mechrgui","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0390","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1258\/ijsa.2011.010476","article-title":"Co-trimoxazole-induced myopia in an HIV-positive patient","volume":"23","author":"Kamath","year":"2012","journal-title":"Int J STD AIDS"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0395","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/IJG.0b013e31829539f4","article-title":"Late acute myopia syndrome induced by combination of sulfonamide drugs","volume":"23","author":"Kozner","year":"2014","journal-title":"J Glaucoma"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0400","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9394(14)71972-5","article-title":"Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusion","volume":"122","author":"Postel","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2024.102191_b0405","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/OPX.0b013e3182297d44","article-title":"Secondary pseudomyopia induced by amisulpride","volume":"88","author":"Stratos","year":"2011","journal-title":"Optom vis Sci"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0410","first-page":"516","article-title":"Aripiprazole-induced transient myopia","volume":"7","author":"Cumurcu","year":"2020","journal-title":"North Clin Istanb"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0415","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5152\/balkanmedj.2015.15292","article-title":"Aripiprazole induced acute transient bilateral myopia: a case report","volume":"32","author":"Karadag","year":"2015","journal-title":"Balkan Med J"},{"key":"10.1016\/j.clae.2024.102191_b0420","first-page":"S147","article-title":"Aripiprazole induced acute myopia: a case report","volume":"19","author":"Kaya","year":"2009","journal-title":"Klinik Psikofarmakoloji Bulteni-Bull. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0425","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/15569527.2011.603106","article-title":"Aripiprazole induced transient myopia: a case report and review of literature","volume":"31","author":"Nair","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clae.2024.102191_b0430","doi-asserted-by":"crossref","unstructured":"Kumar R, Sachdev PS. Akathisia and second-generation antipsychotic drugs. Curr Opin Psychiatry. 2009;22(3):293-99.","DOI":"10.1097\/YCO.0b013e32832a16da"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0435","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/ijo.IJO_907_16","article-title":"Aripiprazole-induced transient myopia: a rare entity","volume":"66","author":"Praveen Kumar","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0440","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1475-1313.1995.9500076p.x","article-title":"Reversal of tropicamide mydriasis with single instillations of pilocarpine can induce substantial pseudo-myopia in young adults","volume":"15","author":"Gilmartin","year":"1995","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0445","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1475-1313.2003.00136.x","article-title":"Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine","volume":"23","author":"Santodomingo-Rubido","year":"2003","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clae.2024.102191_b0450","doi-asserted-by":"crossref","unstructured":"Paz T, Rappoport D, Hilely A, Leiba H. Bilateral transient myopia with sulfasalazine treatment. Clin Med Insights Case Rep. 2019;12:1179547619855388.","DOI":"10.1177\/1179547619855388"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0455","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-13-58","article-title":"Indapamide-induced transient myopia with supraciliary effusion: Case report","volume":"13","author":"V\u00e9gh","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clae.2024.102191_b0460","first-page":"1486128","article-title":"Bilateral angle narrowing and acute myopia induced by indapamide: a case report","volume":"2018","author":"Pedrosa","year":"2018","journal-title":"Case Rep Ophthalmol Med"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0465","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12886-020-01635-2","article-title":"Acute bilateral myopia induced by Triplixam: a case report","volume":"20","author":"Jaruseviciene","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0470","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12886-021-02147-3","article-title":"Multimodal imaging of indapamide-induced bilateral choroidal effusion: a case report","volume":"21","author":"Takahashi","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"50","key":"10.1016\/j.clae.2024.102191_b0475","doi-asserted-by":"crossref","first-page":"e9257","DOI":"10.1097\/MD.0000000000009257","article-title":"Bilateral acute myopia and angle closure glaucoma induced by Ma-huang (Ephedra): a case report","volume":"96","author":"Ryu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0480","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000027406","article-title":"Transient acute myopia induced by antilymphocyte globulins","volume":"213","author":"Milea","year":"1999","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0485","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/OPX.0000000000000766","article-title":"Relenza-induced acute myopia change","volume":"93","author":"Weng","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0490","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0301-4738.55066","article-title":"Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and choroidal detachment","volume":"57","author":"Vishwakarma","year":"2009","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0495","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1475-1313.2008.00590.x","article-title":"Drug-induced ocular side-effects with isotretinoin","volume":"28","author":"Santodomingo-Rubido","year":"2008","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0500","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5334\/joc.18","article-title":"Pupillometry: psychology, physiology, and function","volume":"1","author":"Mathot","year":"2018","journal-title":"J Cogn"},{"issue":"8","key":"10.1016\/j.clae.2024.102191_b0505","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/OPX.0000000000001924","article-title":"Topical review: pilocarpine-induced miosis as help for early presbyopes?","volume":"99","author":"Westheimer","year":"2022","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0510","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2022.10781","article-title":"Pharmacological treatment of presbyopia: a systematic review","volume":"32","author":"Haghpanah","year":"2022","journal-title":"Eur J Transl Myol"},{"key":"10.1016\/j.clae.2024.102191_b0515","unstructured":"Vuity. FDA NDA 214028 2021 [cited 2024 April]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/214028s002lbl.pdf."},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0520","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40123-022-00482-2","article-title":"In vitro and in-eye comparison of commercial pilocarpine ophthalmic solution and an optimized, reformulated pilocarpine for presbyopia treatment","volume":"11","author":"Jackson","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.clae.2024.102191_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100065","article-title":"Combinations of pilocarpine and oxymetazoline for the pharmacological treatment of presbyopia: two randomized phase 2 studies","volume":"1","author":"Price","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"10.1016\/j.clae.2024.102191_b0530","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00417-021-05138-8","article-title":"A multicentric study of pharmacological treatment for presbyopia","volume":"259","author":"Benozzi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.clae.2024.102191_b0535","first-page":"2903","article-title":"Evaluating vision-related reading ability with a de novo PRO instrument in a phase 3 study of AGN-190584 (pilocarpine 1.25%) for presbyopia","volume":"62","author":"Price","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2024.102191_b0540","unstructured":"Pepose JS, Kolli A, Patel R, Rahmani K, Sooch M, Brigell MG, et al. The efficacy of phentolamine ophthalmic solution and low-dose pilocarpine to improve distance-corrected intermediate visual acuity in patients with presbyopia. Invest Ophthalmol Visual Sci 2022;63(7):1809 \u2013 F0425-1809 \u2013 F0425."},{"key":"10.1016\/j.clae.2024.102191_b0545","unstructured":"Szekely G, Raymond ID, Vangyi C, Shiah J, Akunuri V, Panwala C, et al. A novel pilocarpine ophthalmic topical cream formulation applied to eyelids is well tolerated, supporting its clinical evaluation for the treatment of dry eye disease and presbyopia. Invest Ophthalmol Visual Sci 2022;63(7):2002 \u2013 A0332-2002 \u2013 A0332."},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051385","article-title":"Pharmacological treatment in presbyopia","volume":"11","author":"Grzybowski","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.clae.2024.102191_b0555","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3928\/23258160-20220629-01","article-title":"Vitreofoveal traction associated with pilocarpine for presbyopia","volume":"53","author":"Amarikwa","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.clae.2024.102191_b0560","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajo.2022.05.011","article-title":"Retinal detachments associated with topical pilocarpine use for presbyopia","volume":"242","author":"Al-Khersan","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0565","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijo.IJO_1901_22","article-title":"Pilocarpine 1.25% for the treatment of presbyopia","volume":"71","author":"Mansoori","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102191_b0570","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40135-023-00307-w","article-title":"Review of pharmacological treatments for presbyopia","volume":"11","author":"Vejarano","year":"2023","journal-title":"Curr Ophthalmol Rep"},{"issue":"6","key":"10.1016\/j.clae.2024.102191_b0575","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/jf052651q","article-title":"Astaxanthin protects against oxidative stress and calcium-induced porcine lens protein degradation","volume":"54","author":"Wu","year":"2006","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clae.2024.102191_b0580","first-page":"170","article-title":"Effects of astaxanthin on accommodation, critical flicker fusion, and pattern visual evoked potential in visual display terminal workers","volume":"19","author":"Nagaki","year":"2002","journal-title":"J Tradit Med"},{"issue":"5","key":"10.1016\/j.clae.2024.102191_b0585","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12603-012-0059-3","article-title":"Improvement of accommodation with anti-oxidant supplementation in visual display terminal users","volume":"16","author":"Uchino","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.clae.2024.102191_b0590","first-page":"3180","article-title":"Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells","volume":"17","author":"Gao","year":"2011","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0595","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5455\/aim.2020.28.170-179","article-title":"An in silico approach reveals the potential function of cyanidin-3-o-glucoside of red rice in inhibiting the advanced glycation end products (AGES)-receptor (RAGE) signaling pathway","volume":"28","author":"Agustin","year":"2020","journal-title":"Acta Inform Med"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0600","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/187152221402150408111137","article-title":"Effect of multiple dietary supplement containing lutein, astaxanthin, cyanidin-3-glucoside, and DHA on accommodative ability","volume":"14","author":"Kono","year":"2014","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"2","key":"10.1016\/j.clae.2024.102191_b0605","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7888\/juoeh.9.127","article-title":"Effect of methylcobalamin in accommodative dysfunction of eye by visual load","volume":"9","author":"Iwasaki","year":"1987","journal-title":"J UOEH"},{"key":"10.1016\/j.clae.2024.102191_b0610","article-title":"Oral consumption of \u03b1-glucosyl-hesperidin could prevent lens hardening, which causes presbyopia","volume":"25","author":"Nakazawa","year":"2021","journal-title":"Biochem Biophys Rep"},{"issue":"3","key":"10.1016\/j.clae.2024.102191_b0615","first-page":"1258","article-title":"Oral intake of \u03b1-glucosyl-hesperidin ameliorates selenite-induced cataract formation","volume":"21","author":"Nakazawa","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clae.2024.102191_b0620","unstructured":"Benozzi JL. Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia. EP 1 938 839 B1. 2006."},{"key":"10.1016\/j.clae.2024.102191_b0625","unstructured":"Benozzi JL. Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia. AU 2007335919 B2. 2007."},{"key":"10.1016\/j.clae.2024.102191_b0630","unstructured":"Horn G, Nordan L. Compositions and methods for the treatment of presbyopia. US 9,089,562 B2; 2014."},{"key":"10.1016\/j.clae.2024.102191_b0635","unstructured":"Horn G, Nordan L. Compositions and methods for the treatment of presbyopia. US 9,968,594 B2; 2015."},{"key":"10.1016\/j.clae.2024.102191_b0640","unstructured":"Horn G, Nordan L. Compositions and methods for the treatment of presbyopia. US 10,064,818 B2; 2015."},{"key":"10.1016\/j.clae.2024.102191_b0645","unstructured":"Horn G, Nordan L. Compositions and methods for the treatment of presbyopia. US 10,959,990 B2; 2015."},{"key":"10.1016\/j.clae.2024.102191_b0650","unstructured":"Kaufman HE. Preparations and methods for ameliorating or reducing presbyopia. US 8,455,494 B2; 2012."},{"key":"10.1016\/j.clae.2024.102191_b0655","unstructured":"Feinbaum C, Salamun F, Patel S. Ophthalmic pharmaceutical compositions and uses relating thereto. EP 3 500 255 B1. EP 3 500 255 B1; 2016."},{"key":"10.1016\/j.clae.2024.102191_b0660","unstructured":"Sanchez Galeana CS. Synergistic ophthalmological composition in a low-concentration dose that is effective in the prevention, control and eradication of presbyopia. WO2022103250 A1. WO2022103250 A1. 2021."},{"key":"10.1016\/j.clae.2024.102191_b0665","unstructured":"Shah MVea. Gel ophthalmic formulations of pilocarpine and brimonidine compound and related methods. US2023\/0248701 A1. US2023\/0248701 A1; 2023."},{"key":"10.1016\/j.clae.2024.102191_b0670","unstructured":"Shah MVea. Ophthalmologically suitable low PKA buffer-containing pilocarpine compositions and related methods. US2023\/0263727 A1; 2023."},{"key":"10.1016\/j.clae.2024.102191_b0675","unstructured":"Sambursky RP, Kaufman HE. Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality. WO2020\/252057 A1. 2020."},{"key":"10.1016\/j.clae.2024.102191_b0680","unstructured":"Sambursky RP, Kaufman HE. Carabachol-bromonidine formulations to enhance anti-presbyopia effects. WO2020\/252061 A1. 2020."},{"key":"10.1016\/j.clae.2024.102191_b0685","unstructured":"Garner W, Garner M, Blum RD. Caged mercaptan and seleno-mercaptan compounds and methods of using them. US 8,697,109 B2. 2008."},{"key":"10.1016\/j.clae.2024.102191_b0690","unstructured":"Till JS, Blum RD. Presbyopia treatment by lens Alteration. US 9204,996 B2. 2014."},{"key":"10.1016\/j.clae.2024.102191_b0695","unstructured":"Till JSB, R. D. Burns W. R. (2007) Presbyopia treatment by lens Alteration. Presbyopia treatment by lens Alteration. US 8,147,816 B2; 2007."},{"key":"10.1016\/j.clae.2024.102191_b0700","unstructured":"Till JSea. Method for delivery of pharmaceuticals for treating or preventing presbyopia. US 7,914,815 B2; 2005."},{"key":"10.1016\/j.clae.2024.102191_b0705","unstructured":"Garner Wea. Choline esters. US 9,326,970 B2; 2014."},{"key":"10.1016\/j.clae.2024.102191_b0710","unstructured":"Burns W, Garner M, Garner WH. Lipoic acid choline ester compositions and methods of use. US 2020\/0281891 A1; 2019."},{"key":"10.1016\/j.clae.2024.102191_b0715","unstructured":"Burns W, Garner M, Garner WH. Lipoic acid choline ester compositions and methods of use. US 11,426,381 B2; 2019."},{"key":"10.1016\/j.clae.2024.102191_b0720","unstructured":"Garner W, Garner M. Low dose lipoic acid pharmaceutical compositions and methods. US 9,517,225 B2; 2015."},{"key":"10.1016\/j.clae.2024.102191_b0725","unstructured":"Garner Wea. Methods of treating presbyopia using dithiol compounds and their derivatives. US 10,039,743 B2; 2016."},{"key":"10.1016\/j.clae.2024.102191_b0730","unstructured":"Garner Wea. Choline esters. US 2022\/0151988; 2022."}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T07:56:11Z","timestamp":1728287771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1367048424000833"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102191","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapies","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102191"}}